Moderna Newsroom

Moderna Analyst Ratings

BenzingaJan 8 10:05 ET

Bernstein Maintains Moderna(MRNA.US) With Hold Rating, Maintains Target Price $55

Moomoo NewsJan 8 07:38 ET

UBS Maintains Moderna(MRNA.US) With Buy Rating, Cuts Target Price to $96

Moomoo NewsJan 8 07:34 ET

Argus Research Downgrades Moderna(MRNA.US) to Hold Rating

Moomoo NewsDec 18, 2024 12:31 ET

Moderna Analyst Ratings

BenzingaDec 18, 2024 11:17 ET

Argus Research Downgrades Moderna(MRNA.US) to Hold Rating

Moomoo NewsDec 18, 2024 07:32 ET

BofA Securities Initiates Moderna(MRNA.US) With Sell Rating, Announces Target Price $41

Moomoo NewsDec 11, 2024 03:31 ET

Moderna Analyst Ratings

BenzingaDec 10, 2024 07:31 ET

Piper Sandler Maintains Moderna(MRNA.US) With Buy Rating, Maintains Target Price $69

Moomoo NewsDec 6, 2024 07:33 ET

Moderna Analyst Ratings

BenzingaNov 26, 2024 09:43 ET

JPMorgan Adjusts Price Target on Moderna to $45 From $59, Maintains Underweight Rating

MT NewswiresNov 26, 2024 05:35 ET

Jefferies Downgrades Moderna(MRNA.US) to Hold Rating, Cuts Target Price to $50

Moomoo NewsNov 22, 2024 12:31 ET

Baptista Upgrades Moderna to Buy, Price Target at $48

MT NewswiresNov 20, 2024 05:18 ET

Berenberg Bank Initiates Moderna(MRNA.US) With Hold Rating, Announces Target Price $42

Moomoo NewsNov 19, 2024 05:34 ET

Berenberg Bank Initiates Moderna(MRNA.US) With Hold Rating, Announces Target Price $42

Moomoo NewsNov 19, 2024 03:44 ET

Piper Sandler Reiterates Overweight on Moderna, Lowers Price Target to $69

BenzingaNov 18, 2024 12:21 ET

Moderna Analyst Ratings

BenzingaNov 18, 2024 09:13 ET

HSBC Upgrades Moderna to Buy From Hold, Adjusts Price Target to $58 From $82

MT NewswiresNov 18, 2024 05:47 ET

Moderna Analyst Ratings

BenzingaNov 15, 2024 05:37 ET

Wolfe Research Downgrades Moderna(MRNA.US) to Sell Rating, Cuts Target Price to $40

Moomoo NewsNov 14, 2024 16:32 ET